We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
-2.72%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$845M
AUM Growth
-$119M
Cap. Flow
-$90.2M
Cap. Flow %
-10.68%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$51.6M
2
DKNG icon
DraftKings
DKNG
+$38.6M

Sector Composition

Rank Sector Weight
1 Communication Services 59.8%
2 Consumer Discretionary 37.38%
3 Healthcare 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAS
1
DELISTED
Integral Ad Science
IAS
$469M 55.51%
22,722,770
– –
DKNG icon
2
DraftKings
DKNG
$11.4B
$316M 37.38%
6,555,608
-728,400
-10% -$38.6M
SNAP icon
3
Snap
SNAP
$7.32B
$18.1M 2.15%
245,559
– –
ROKU icon
4
Roku
ROKU
$21.1B
$18.1M 2.14%
57,707
– –
BCYC
5
Bicycle Therapeutics
BCYC
$270M
$12.8M 1.52%
307,696
– –
FSTX
6
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$4.21M 0.5%
574,996
– –
VRDN icon
7
Viridian Therapeutics
VRDN
$2.13B
$3.45M 0.41%
209,505
– –
LRMR icon
8
Larimar Therapeutics
LRMR
$416M
$3.37M 0.4%
292,184
– –
TBIO
9
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-1,872,115
Closed -$51.6M

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Atlas Venture Advisors held 9 positions worth $845M, down 12% from $963M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors withdrew a net $90.2M in Q3 2021, closing 1 position and reducing 1 holding. Its most notable exit was Translate Bio, Inc. Common Stock, an estimated $51.6M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 60% of assets, up from 53% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Atlas Venture Advisors's biggest Q3 2021 reduction was DraftKings, cutting an estimated $38.6M.
  • Atlas Venture Advisors fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $51.6M.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $845M portfolio in Q3 2021.
  • Atlas Venture Advisors opened 0 new positions and closed 1 in Q3 2021.
  • Atlas Venture Advisors's portfolio value fell 12% quarter-over-quarter to $845M.

Based on Atlas Venture Advisors's 13F filing for Q3 2021, filed 4 Nov 2021.